Aptar Group – a drug delivery, dosing and protection technologies firm – has named Gael Touya President and CEO.
Touya will succeed Stephan Tanda, who has served as President and CEO of the firm since 2017, on 1 September 2026.
Tanda will work closely with Touya, who most recently served as Aptar Pharma President, to ensure a “seamless transition as the company enters its next phase of growth”.
For companies working on next-generation beauty solutions, the Cosmetics Business Innovation Awards provide an industry-wide platform to showcase and explain meaningful innovation. Entries open now! LINK
Aptar Group’s board will also appoint Touya as a Director on 1 September 2026.
“Gael has played a pivotal role in shaping Aptar Pharma’s strategic direction, expanding our technologies and services to support customers from formulation to patient,” said Candace Matthews, Chairperson of Aptar Group.
“His global experience and deep understanding of each of Aptar’s businesses, core technologies and end markets make him uniquely equipped to lead the company forward.
“Following a thorough succession planning and selection process that considered both internal and external candidates, the board unanimously concluded that Gael was the best choice to lead Aptar into its next chapter.”
With more than three decades experience at Aptar across Europe, Asia and North America, Touya is said to bring “deep commercial, operational and technical expertise”.
During his tenure at Aptar Pharma, he led the expansion of the segment’s technologies and services to create an integrated, end‑to‑end model designed to help customers move from early formulation through clinical development and commercialisation with greater efficiency.
Tanda added: “Gael is uniquely qualified to take on the role of President and CEO.
“His global perspective, strong commercial and operational background, and deep understanding of Aptar’s business position him to drive our next chapter of growth.
“His leadership philosophy is grounded in curiosity, collaboration, and creating lasting impact for patients, consumers and customers worldwide.”
Aptar also recognised the leadership of Tanda, and said in a statement that his tenure as CEO since 2017 has been defined by “performance, purpose and global expansion”.
This includes overseeing the acquisition of the Active Material Science business in 2018.
Tanda continued: “I am profoundly grateful to our employees, customers, stakeholders and board for their trust and support during my tenure.
“Leading Aptar has been an immensely rewarding experience, and I appreciate the continued partnership with Gael that has strengthened our company and advanced our mission.”
Related content:
- Puig names Jose Manuel Albesa CEO to lead ‘next chapter’
- Philip Kingsley names new CEO to lead ‘new era’ of iconic hair care brand
- Wella Company taps ex-Sephora Americas boss Calvin McDonald as new CEO
- Albéa to acquire Amfora Packaging in ‘significant milestone’ to boost Latin America growth
- Virospack owner acquires Eurovetrocap packaging firm
- Givaudan to snap up majority stake in Brazilian fragrance supplier Vollmens
